Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.00
Bid: 314.00
Ask: 315.80
Change: -0.40 (-0.13%)
Spread: 1.80 (0.573%)
Open: 307.00
High: 315.40
Low: 307.00
Prev. Close: 314.40
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Perpetua Labs Inc

15 Apr 2021 07:00

RNS Number : 5181V
Ascential PLC
15 April 2021
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATIONS.

 

 

15 April 2021

 

Ascential plc

 

Acquisition of Perpetua

 

 

Ascential plc (LSE: ASCL.L), the specialist information, analytics and eCommerce optimisation company, today announces the acquisition of Perpetua Labs Inc, an eCommerce media optimisation business that primarily targets Third party (3P1) sellers.

 

Perpetua provides a self-service SaaS platform that helps independent sellers, as well as agencies and some larger brands, optimise the purchase of search and display advertising on Amazon and other major marketplaces. This marks new territory for Ascential's Digital Commerce segment, which the business will join, and which to date has exclusively served first party (1P) vendors. Perpetua has 66 staff, based primarily in Toronto, which include the founder and CEO Rosco Hill who is the largest shareholder.

 

The acquisition is for an initial cash consideration of US$52m, plus deferred consideration payable over four years, resulting in an estimated total consideration (including the initial consideration) of between US$103m and US$162m. Total consideration payable for Perpetua, in the event that very stretching targets are reached, is capped at US$250m.

 

In the year ended December 2020 Perpetua recorded revenue of US$3.8m (growth of over 3x vs 2019) and an EBITDA loss of US$0.2m. At December 2020 it had annualised MRR2 of US$7.4m, with gross assets of US$10.9m.

 

Duncan Painter, CEO of Ascential, commented:

"Perpetua's expertise serving third party vendors, through data-driven solutions, opens the door for Ascential to this large and fast-growing market segment. Combined with the global reach of our existing Digital Commerce businesses, that provide a full service offering to larger, First party, brands, we have the exciting opportunity, with Perpetua, to expand our offerings across further platforms and geographies."

 

 

1 3P: Third (vs First) party, selling directly to consumers, via digital platforms

2 Monthly Recurring Revenue

 

 

 

Contacts

 

Ascential plc

Duncan Painter

Chief Executive Officer

+44 (0)20 7516 5000

Mandy Gradden

Chief Financial Officer

Rory Elliott

Investor Relations Director

Media enquiries

Edward Bridges, Matt Dixon, Jamie Ricketts

FTI Consulting LLP

+44 (0)20 3727 1017

 

 

About Ascential

Ascential delivers specialist information, analytics and eCommerce optimisation platforms to the world's leading consumer brands and their ecosystems.

 

Our world-class businesses improve performance and solve problems for our customers by delivering immediately actionable information combined with visionary longer-term thinking across Digital Commerce, Product Design and Marketing. We also serve customers across Retail & Financial Services.

 

· Digital Commerce - measurement, optimisation and execution for digital commerce growth.

· Product Design - consumer product trend forecasting, data and insight to create world-class products and experiences.

· Marketing - services and tools to measure and optimise marketing creativity, media and platform effectiveness and efficiency.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQLZLLFFZLLBBZ
Date   Source Headline
16th Nov 202311:57 amRNSHolding(s) in Company
6th Nov 20232:46 pmRNSHolding(s) in Company
6th Nov 202312:22 pmRNSHolding(s) in Company
3rd Nov 20232:43 pmRNSHolding(s) in Company
2nd Nov 20233:46 pmRNSHolding(s) in Company
2nd Nov 202310:29 amRNSHolding(s) in Company
1st Nov 20234:18 pmRNSHolding(s) in Company
1st Nov 20231:50 pmRNSHolding(s) in Company
1st Nov 202311:22 amRNSDirector/PDMR Shareholding
31st Oct 20231:12 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSUpdate on investment in Hudson MX
30th Oct 20237:00 amRNSProposed sale of Digital Commerce and WGSN
24th Oct 20237:00 amRNSHolding(s) in Company
16th Oct 202310:23 amRNSHolding(s) in Company
2nd Oct 202311:59 amRNSTotal Voting Rights
22nd Sep 20237:00 amRNSHalf year results
7th Sep 20235:55 pmRNSBoard change
30th Aug 20239:48 amRNSBlock listing application
24th Aug 20234:05 pmRNSBlock listing Interim Review
24th Aug 202311:48 amRNSDirector Declaration
10th Aug 20234:41 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:47 amRNSTotal Voting Rights
5th Jun 20237:00 amRNSNotice of Capital Markets Event
1st Jun 202310:38 amRNSTotal Voting Rights
18th May 202310:46 amRNSResult of AGM
17th Apr 20233:18 pmRNSDirector/PDMR Shareholding
17th Apr 202310:02 amRNSHolding(s) in Company
4th Apr 20236:15 pmRNSHolding(s) in Company
3rd Apr 202311:33 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSFinal Results
23rd Mar 20234:27 pmRNSHolding(s) in Company
20th Mar 20234:50 pmRNSHolding(s) in Company
15th Mar 202312:31 pmRNSHolding(s) in Company
1st Mar 20232:22 pmRNSTotal Voting Rights
24th Feb 202312:38 pmRNSDirector/PDMR Shareholding
20th Feb 202311:12 amRNSDirector/PDMR Shareholding
17th Feb 20233:22 pmRNSHolding(s) in Company
16th Feb 202312:48 pmRNSHolding(s) in Company
7th Feb 20237:00 amRNSUpdate on investment in Hudson MX
1st Feb 20232:10 pmRNSTotal Voting Rights
25th Jan 20237:00 amRNSTrading update and conclusion of strategic review
7th Dec 202212:17 pmRNSHolding(s) in Company
1st Dec 202212:04 pmRNSTotal Voting Rights
21st Nov 202211:53 amRNSHolding(s) in Company
17th Nov 20221:36 pmRNSHolding(s) in Company
12th Oct 20223:10 pmRNSDirector/PDMR Shareholding
11th Oct 202212:29 pmRNSDirector/PDMR Shareholding
3rd Oct 20229:40 amRNSTotal Voting Rights
15th Sep 202210:42 amRNSExternal Directorship
12th Sep 20227:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.